Modular Medical Announces Commercial Availability of Pivot Tubeless Insulin Patch Pump Ahead of Commercial ExpansionThe Pivot tubeless insulin patch pump is now commercially available in the U.S. following FDA 510(k) clearance in April
Modular Medical Appoints Kevin Schmid as Chief Operating OfficerSchmid brings 40 years of experience in medical devices for drug delivery and diabetes management and a background in high-volume manufacturing
Modular Medical to Present at LD Micro Invitational XII Investor ConferenceSAN DIEGO, CA / ACCESSWIRE / June 2, 2022 / Modular Medical Inc. (the "Company" or "Modular Medical") (
NASDAQ:MODD), a development stage, insulin delivery technology company seeking to launch the next generation of easy to use and affordable insulin pump technology, today announced that Jeb Besser, the Company's Chief Executive Officer, is scheduled to present at the LD Micro Invitational XII Investor Conference on Wednesday, June 8, 2022 at 3:30 PM PT, at the Four Seasons Hotel in Westlake Village, California.
Modular Medical to Present at Spring Into Action - Best Ideas Virtual Investor Conference on May 18, 2022SAN DIEGO, CA / ACCESSWIRE / May 12, 2022 / Modular Medical, Inc. ("Modular Medical") (
NASDAQ:MODD), a development stage, insulin delivery technology company seeking to launch the next generation of easy to use and affordable insulin pump technology, today announced that Jeb Besser, CEO, is scheduled to present at the Spring Into Action - Best Ideas Virtual Investor Conference on May 18, 2022 at 1:00 p.m. ET. Mr. Besser will also host meetings
Modular Medical Announces $8 Million Registered Direct OfferingOur newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence.
Modular Medical to Present at the Oppenheimer 32nd Annual Healthcare ConferenceSAN DIEGO, CA / ACCESSWIRE / March 3, 2022 / Modular Medical Inc. (the "Company" or "Modular Medical") (
NASDAQ:MODD), a development stage, insulin delivery technology company seeking to launch the next generation of easy to use and affordable insulin pump technology, today announced that the Company will present at Oppenheimer's 32nd Annual Healthcare Conference. Jeb Besser, the Company's Chief Executive Officer, will represent the Company in a
Modular Medical Appoints James "Jeb" Besser as Chief Executive OfficerLynn Vos to remain on board of directors Besser brings 25 years of experience in life sciences, technology, capital markets Company reaffirms timeline for 510(k) submission of MODD1 insulin pump to FDA SAN DIEGO, CA / ACCESSWIRE / February 24, 2022 / Modular Medical, Inc. (the "Company" or "Modular Medical")(
NASDAQ:MODD) today announced that its board of directors has appointed James "Jeb" Besser as Chief Executive Officer. Besser, a company
Modular Medical Announces Pricing of $15 Million Public Offering and Uplisting to the Nasdaq Capital MarketSAN DIEGO, CA / ACCESSWIRE / February 10, 2022 / Modular Medical, Inc., (
NASDAQ:MODD) (the "Company" or "Modular Medical"), a development-stage insulin pump company focused on providing insulin delivery without complexity to increase pump adoption and reduce the burden of diabetes care for clinicians and individuals living with diabetes, announced today the pricing of its underwritten public offering of 2,500,000 units at a price to the public of
Steven G. Felsher and Philip B. Sheibley Appointed to Board of Directors of Modular Medical, Inc.SAN DIEGO, CA / ACCESSWIRE / November 29, 2021 / Modular Medical, Inc. (the "Company" or "Modular Medical") (OTCQB:MODD), a development-stage insulin pump company focused on providing insulin delivery without complexity to increase pump adoption and reduce the burden of diabetes care for clinicians and individuals living with diabetes, today announced the expansion of its Board of Directors with the appointment of two
Modular Medical, Inc. Announces Reverse Stock Split in Connection with Application for Uplisting on the NASDAQ Capital MarketSAN DIEGO, CA / ACCESSWIRE / November 26, 2021 / Modular Medical, Inc. (the "Company") (OTCQB:MODD), a development-stage insulin pump company focused on providing insulin delivery without complexity to increase pump adoption and reduce the burden of diabetes care for clinicians and individuals living with diabetes, today announced a "reverse split" of its shares of common stock at a ratio of 1-for-3. The Company's common stock will begin trading
Modular Medical Expands Executive Team with Appointment Of Lynn O'Connor Vos as New CEOO'Connor Vos Brings Deep Experience in Market Development, Commercializing Products and Patient Advocacy SAN DIEGO, CA / ACCESSWIRE / August 16, 2021 / Modular Medical, Inc. (OTCQB:MODD), a development-stage insulin pump company focused on providing insulin delivery without complexity to increase pump adoption and reduce the burden of diabetes care for clinicians and individuals living with diabetes, today announced the expansion of its
Modular Medical Welcomes Global Healthcare Leader Lynn Vos to its Board of DirectorsSAN DIEGO, CA / ACCESSWIRE / May 25, 2021 / Modular Medical, Inc. (OTCQB:MODD), a medical device company focused on next generation insulin delivery technologies to widen the accessibility of insulin pumps to a greater share of people with type 1 and type 2 diabetes, is pleased to announce the appointment ofindustry veteran Lynn O'Connor Vos to its board of directors. Ms. Vos brings decades of experience in building innovative businesses
Modular Medical Announces FinancingSAN DIEGO, CA / ACCESSWIRE / May 12, 2021 / Modular Medical, Inc. (OTCQB:MODD), a medical device company focused on next generation insulin delivery technologies to widen the accessibility of insulin pumps to a greater share of people with type 1 and type 2 diabetes, announced today that it has entered into definitive agreements for a private placement of $6.6 million of convertible promissory notes. The company intends to use the net
